As mentioned previously, data on the increased severity of COVID-19 in patients with no endogenous IFN-β and low IFN-α production or with neutralizing auto-Abs against these type I IFNs [3,11] have strongly suggested a potential role for IFN [12]. This evidence concerns the gene IFNB1 and COVID-19.